Max Reinhardt

2020

In 2020, Max Reinhardt earned a total compensation of $2.3M as President, Rest of World at Pacira Pharmaceuticals, a 50% decrease compared to previous year.

Compensation breakdown

Bonus$268,200
Option Awards$784,839
Salary$555,000
Stock Awards$667,100
Other$26,957
Total$2,302,096

Reinhardt received $784.8K in option awards, accounting for 34% of the total pay in 2020.

Reinhardt also received $268.2K in bonus, $555K in salary, $667.1K in stock awards and $27K in other compensation.

Rankings

In 2020, Max Reinhardt's compensation ranked 4,909th out of 13,090 executives tracked by ExecPay. In other words, Reinhardt earned more than 62.5% of executives.

ClassificationRankingPercentile
All
4,909
out of 13,090
63rd
Division
Manufacturing
1,993
out of 5,620
65th
Major group
Chemicals And Allied Products
790
out of 2,253
65th
Industry group
Drugs
681
out of 1,953
65th
Industry
Pharmaceutical Preparations
512
out of 1,458
65th
Source: SEC filing on April 22, 2022.

Reinhardt's colleagues

We found three more compensation records of executives who worked with Max Reinhardt at Pacira Pharmaceuticals in 2020.

2020

David Stack

Pacira Pharmaceuticals

Chief Executive Officer

2020

Roy Winston

Pacira Pharmaceuticals

Chief Medical Officer

2020

Charles Reinhart

Pacira Pharmaceuticals

Chief Financial Officer

News

You may also like